GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
GH Research PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026
$18.28+0.13 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $1.22B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.79 (+35.51%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.22B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -4.26%
Fundamentals
- Net income
- -$62.27M
- EPS, diluted
- -$1.00
- Free cash flow
- -$51.84M
- Diluted shares
- 67M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Operating income
-$71.49M
Net income
-$62.27M
EPS, diluted
-$1.00
Free cash flow
-$51.84M
Reported periodTrailing twelve months